NCT06540118

Brief Summary

This study will look at the effects of providing medically tailored meals (MTMs) to people with heart disease for twelve weeks. The primary outcome of the study is the quality of the diet being consumed in week 12 of the study, as determined by the "Healthy Eating Index."

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable heart-failure

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable heart-failure

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 24, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

August 6, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

October 17, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 28, 2025

Completed
Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

9 months

First QC Date

July 24, 2024

Last Update Submit

January 22, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in diet quality at Week 12, as determined by the Healthy Eating Index (HEI)

    HEI will be used to determine diet quality based on dietary recall data collected via Nutrition Data System for Research (NDSR) software. HEI scores range from 0 to 100. An ideal overall HEI score of 100 reflects that the set of foods aligns with key dietary recommendations and dietary patterns published in the Dietary Guidelines for Americans.

    Baseline and Week 12

Secondary Outcomes (9)

  • Participant satisfaction with delivery of medically tailored meals for individuals with heart failure

    Week 4 and Week 12

  • Dietary adherence to meal assignment using daily food diaries and 24-hour dietary recalls

    Baseline and Weeks 4, 6, 8, and 12

  • Change in reported access to healthy foods as assessed by the Food Consumption Score (FCS)

    Baseline, Week 12, and Week 24

  • Change in reported food security as assessed by the Food Insecurity Experience Scale (FIES)

    Baseline, Week 12, Week 24

  • Change in reported food security as assessed by the Short Form of the U.S. Adult Food Security Survey Module

    Baseline, Week 12, Week 24

  • +4 more secondary outcomes

Study Arms (2)

15 Medically Tailored Meals (MTM) + snacks

EXPERIMENTAL

Participants will receive 15 medically tailored meals (MTM) per week, plus snacks, for 12 weeks.

Other: 15 Medically Tailored Meals (MTM) per week

14 Medically Tailored Meals (MTM)

EXPERIMENTAL

Participants will receive 14 medically tailored meals (MTM) per week for 12 weeks.

Other: 14 Medically Tailored Meals (MTM) per week

Interventions

14 heart-healthy medically tailored meals delivered to participants each week. Meals include lunch and dinner to consume Monday-Sunday.

14 Medically Tailored Meals (MTM)

15 heart-healthy medically tailored meals delivered to participants each week. Meals include breakfast, lunch, dinner, and snack to consume Monday-Friday.

15 Medically Tailored Meals (MTM) + snacks

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Willingness to comply with all study procedures and availability for the duration of the study
  • Living in San Diego or the Bay Area of California
  • Reported congestive heart failure (CHF) diagnosis
  • Current diet can be improved
  • Willing to eat all meals provided by the study

You may not qualify if:

  • Diagnosed with end-stage heart failure
  • Diagnosed with diabetes (type 1 or uncontrolled type 2)
  • Currently taking insulin and/or meglitinides medications
  • Currently taking Glucagon-Like Peptide-1 (GLP-1) Agonists medications and not stable on a maximum maintenance dose for a minimum of 1 month
  • Hemoglobin A1c (HbA1c) results \>8 %
  • Life expectancy of \<1 year
  • Pregnancy or lactation
  • Known severe allergic reactions and/or food intolerances that would interfere with the ability to eat study-provided meals, including foods that are prepared in a facility that works with the allergen
  • Current smoker or tobacco use within the past year
  • Planning to leave San Diego or the Bay Area during the course of the study
  • Unable to communicate reasonably well either orally or through written material in English
  • Those who, in the opinion of the investigators, cannot reliably complete the study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of California San Diego

La Jolla, California, 92093, United States

Location

Stanford University

Stanford, California, 94305, United States

Location

MeSH Terms

Conditions

Heart FailureHeart Diseases

Interventions

myotubularin

Condition Hierarchy (Ancestors)

Cardiovascular Diseases

Study Officials

  • Cheryl Anderson, PhD, MPH, MS

    UC San Diego

    PRINCIPAL INVESTIGATOR
  • Christopher Gardner, PhD

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
By the nature of the dietary intervention, it is impossible to blind participants to study arm assignment. However, research staff collecting outcome data, apart from dietary adherence data, will remain blinded to participants' assigned study arm throughout data collection. Additionally, the statistician(s) analyzing data for efficacy of the intervention will use a dataset with study arm masked in order to remain blinded to the assigned intervention for the final analysis.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Dean

Study Record Dates

First Submitted

July 24, 2024

First Posted

August 6, 2024

Study Start

October 17, 2024

Primary Completion

July 28, 2025

Study Completion

July 28, 2025

Last Updated

January 26, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations